154 related articles for article (PubMed ID: 8326916)
21. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. A randomized controlled trial.
Graham DY; Lew GM; Evans DG; Evans DJ; Klein PD
Ann Intern Med; 1991 Aug; 115(4):266-9. PubMed ID: 1854110
[TBL] [Abstract][Full Text] [Related]
22. [Eradication of Helicobacter pylori. Effectiveness of a combination of ranitidine and metronidazole/roxithromycin].
Stölzle L
Fortschr Med; 1994 Sep; 112(26):363-4. PubMed ID: 7959514
[TBL] [Abstract][Full Text] [Related]
23. Ranitidine bismuth citrate with clarithromycin given twice daily effectively eradicates Helicobacter pylori and heals duodenal ulcers.
Bardhan KD; Wurzer H; Marcelino M; Jahnsen J; Lotay N; Roberts PM
Am J Gastroenterol; 1998 Mar; 93(3):380-5. PubMed ID: 9517644
[TBL] [Abstract][Full Text] [Related]
24. Duodenal ulcer healing rates in a one-year follow-up study with ranitidine bismuth citrate and antibiotics.
Wurzer H; Bardhan KD; Marcelino M; Jahnsen J; Allmaier M
Hepatogastroenterology; 2001; 48(42):1641-7. PubMed ID: 11813591
[TBL] [Abstract][Full Text] [Related]
25. One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Lara LF; Cisneros G; Gurney M; Van Ness M; Jarjoura D; Moauro B; Polen A; Rutecki G; Whittier F
Arch Intern Med; 2003 Sep; 163(17):2079-84. PubMed ID: 14504122
[TBL] [Abstract][Full Text] [Related]
26. Long-term follow-up and serological study after triple therapy of Helicobacter pylori-associated duodenal ulcer.
Wang WM; Chen CY; Jan CM; Chen LT; Perng DS; Lin SR; Liu CS
Am J Gastroenterol; 1994 Oct; 89(10):1793-6. PubMed ID: 7942669
[TBL] [Abstract][Full Text] [Related]
27. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
[TBL] [Abstract][Full Text] [Related]
28. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
de Boer WA; Haeck PW; Otten MH; Mulder CJ
Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338
[TBL] [Abstract][Full Text] [Related]
29. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
30. [Comparative effect of lansoprazole/amoxicillin with omeprazole/amoxicillin for the eradication of Helicobacter pylori in patients with duodenal ulcer].
Kayser S; Flury R; Zbinden R; Fried M; Wirth HP
Schweiz Med Wochenschr; 1997 Apr; 127(17):722-7. PubMed ID: 9221483
[TBL] [Abstract][Full Text] [Related]
31. Eradication rates of Helicobacter pylori between metronidazole-sensitive and metronidazole-resistant strains with metronidazole containing regimen in Thai patients with peptic ulcer disease.
Wongkusoltham P; Vilaichone RK; Kullavanijaya P; Phaosawadi K; Mahachai V
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S474-80. PubMed ID: 11529378
[TBL] [Abstract][Full Text] [Related]
32. [What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Gisbert JP; Boixeda D; de Rafael L; Alvarez Baleriola I; Martín de Argila C; García M; García Plaza A
Rev Esp Enferm Dig; 1996 Mar; 88(3):179-84. PubMed ID: 8645510
[TBL] [Abstract][Full Text] [Related]
33. Triple therapy with sucralfate is not effective in eradicating Helicobacter pylori and does not reduce duodenal ulcer relapse rates.
Pedrazzoli J; Magalhães AF; Ferraz JG; Trevisan M; De Nucci G
Am J Gastroenterol; 1994 Sep; 89(9):1501-4. PubMed ID: 8079927
[TBL] [Abstract][Full Text] [Related]
34. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy.
Cutler AF; Schubert TT
Am J Gastroenterol; 1993 Sep; 88(9):1359-61. PubMed ID: 8362830
[TBL] [Abstract][Full Text] [Related]
35. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
Tepes B; Kavcic B; Gubina M; Krizman I
Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
[TBL] [Abstract][Full Text] [Related]
36. [A trial of modified triple therapy for the eradication of H. pylori in recurrent duodenal ulcer].
Wirth HP; Wüst J; Flury R; Zala G; Casanova C; Bertschinger P; Ammann R; Münch R
Schweiz Med Wochenschr; 1993 Sep; 123(35):1645-9. PubMed ID: 8211015
[TBL] [Abstract][Full Text] [Related]
37. 7-day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure.
Gisbert JP; Fuentes J; Carpio D; Tito L; Guardiola J; Tomas A; Olivares D; Calvet X
Aliment Pharmacol Ther; 2005 May; 21(10):1249-53. PubMed ID: 15882246
[TBL] [Abstract][Full Text] [Related]
38. A single drug for Helicobacter pylori infection: first results with a new bismuth triple monocapsule.
de Boer WA; van Etten RJ; Schneeberger PM; Tytgat GN
Am J Gastroenterol; 2000 Mar; 95(3):641-5. PubMed ID: 10710051
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
[TBL] [Abstract][Full Text] [Related]
40. Use of high efficacy, lower dose triple therapy to reduce side effects of eradicating Helicobacter pylori.
Borody TJ; Brandl S; Andrews P; Ferch N; Jankiewicz E; Hyland L
Am J Gastroenterol; 1994 Jan; 89(1):33-8. PubMed ID: 8273794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
